Systematic review: hypomagnesaemia induced by proton pump inhibition
Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection
Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - a double-blind, placebo-controlled study
Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS
Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism
Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease
Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study
Admission time is associated with outcome of upper gastrointestinal bleeding: results of a multicentre prospective cohort study
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR)
Commentary: simvastatin as the key to improving H. pylori eradication rates?
Commentary: simvastatin as the key to improving H. pylori eradication rates? Authors’ reply
Commentary: endoscopic dilatation for stricturing Crohn's disease
Letter: anti-TNFs and psoriasis – friends or foes?
Letter: anti-TNFs and psoriasis – friends or foes? Authors’ reply
Letter: infliximab and adalimumab in the management of Crohn's disease – are they really comparable?
Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD
Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD – authors’ reply